Evidence map›Paper›PMID 35243119›Full record

ReviewTranslational gastroenterology and hepatology2022

Rectal Dieulafoy's lesion: a comprehensive review of patient characteristics, presentation patterns, diagnosis, management, and clinical outcomes.

Faisal Inayat, Amna Hussain, Sidra Yahya, Simcha Weissman, Nuraiz Sarfraz, Muhammad Salman Faisal, Iqra Riaz, Saad Saleem, Muhammad Wasif Saif

Abstract readReview
In one paragraph

Review in Translational gastroenterology and hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Rectal Dieulafoy Lesion with Severe Hematochezia in a Warfarin-Treated Patient.Journal of community hospital internal medicine perspectives · 2026
    Article
  7. Fatal exulceratio simplex (dieulafoy lesion) - a case report and review.Forensic science, medicine, and pathology · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Faisal InayatAllama Iqbal Medical College, Lahore, Pakistan.
Amna HussainAllama Iqbal Medical College, Lahore, Pakistan.
Sidra YahyaFatima Jinnah Medical University, Lahore, Pakistan.
Simcha WeissmanHackensack Meridian Health Palisades Medical Center, North Bergen, NJ, USA.
Nuraiz SarfrazKing Edward Medical University, Lahore, Pakistan.
Muhammad Salman FaisalAllegheny General Hospital, Pittsburgh, PA, USA.
Iqra RiazEinstein Medical Center, Philadelphia, PA, USA.
Saad SaleemMercy Saint Vincent Medical Center, Toledo, OH, USA.
Muhammad Wasif SaifThe Feinstein Institute of Medical Research, Manhasset, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dieulafoy's lesion is an abnormally large, tortuous, submucosal vessel that erodes the overlying mucosa, without primary ulceration or erosion. Although these lesions predominantly involve the stomach and upper small intestine, they are being detected with increasing frequency in the rectum. We conducted a systematic literature search of MEDLINE, Cochrane, Embase, and Scopus databases for adult rectal Dieulafoy's lesion. After careful review of the search results, a total of 101 cases were identified. The data on patient characteristics, clinical features, colonoscopy findings, diagnosis, treatment, and clinical outcomes were collected and analyzed. The mean age of presentation was 66±17 years (range, 18-94 years), with 54% of cases reported in males. Clinical presentation was dominated by acute lower gastrointestinal bleeding in the form of bright-red blood per rectum 47% and hematochezia 36%, whereas 16% of patients were admitted with symptoms related to other medical conditions. Major underlying disorders were hypertension 29%, diabetes mellitus 21%, and chronic kidney disease 16%. The average number of colonoscopies required for the diagnosis of rectal Dieulafoy's lesion was 1.5±0.7. In regard to treatment, endoscopic therapy was applied in 80%, direct surgical suturing in 12%, angiographic embolization in 4%, and endoscopic therapy followed by surgical ligation was performed in 4% of patients. The endoscopic treatment was a feasible choice for rectal disease, with a primary hemostasis rate of 88%. Although the overall mortality rate was 6%, the causes of death were unrelated to this entity. This review illustrates that patients with rectal Dieulafoy's lesion can have a favorable clinical outcome. Prompt diagnosis and appropriate management are of paramount importance to prevent serious hemodynamic complications. The best therapeutic modality remains to be determined but the data presented here support the use of mechanical endoscopic methods as safe and effective.

Indexed as

clinical outcomesclinical presentationcolonoscopydiagnosisgastrointestinal bleedingmanagementmechanical endoscopic therapypatient characteristicsRectal Dieulafoy’s lesion

Identifiers

PMID35243119
PMCPMC8826214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.